Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DouYu International Holdings Limited Filed Its Annual Report on Form 20-F

prnewswire.com
DOYU

Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris

globenewswire.com
ABBV AMGN PFE VTRS

Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris

globenewswire.com
ABBV AMGN PFE VTRS

Multinational giants step up presence in north China's tech zone TEDA

globenewswire.com
VWAGY OTIS NVO

Gravity Energy Storage Market Research and Global Long-term Forecast Report 2026-2040: Advancements Drive Growth in Solid Gravity Energy Storage, Fostering Effective, Eco-friendly Applications

globenewswire.com
NRG NEE BE GE ES

Gravity Energy Storage Market Research and Global Long-term Forecast Report 2026-2040: Advancements Drive Growth in Solid Gravity Energy Storage, Fostering Effective, Eco-friendly Applications

globenewswire.com
NRG GE

12 Press Releases You Need to See This Week

prnewswire.com
ABT BAC PNC GPRO

As Clinicians Leave Traditional Medicine to Build a Better Model, Ultralight Raises $9.3M to Power What Comes Next

businesswire.com
STRD

Regions Reports earnings of $539 million and EPS of $0.62 in 1Q 2026

businesswire.com
RF

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

globenewswire.com
KURA
View all news →